Glaukos Corp (GKOS): Capital Expenditures
$7.67M
Year ended 2025-12-31
$11.25M
Trailing 12 months to 2026-06-30
-36.7%
3-year compound annual growth
+2.0%
5-year compound annual growth
+24.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.67M | +21.7% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $6.30M | -68.9% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $20.25M | -33.1% | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | $30.27M | -36.7% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $47.78M | +589.0% | 2024-02-23, From 2021-01-01 |
| 2020-12-31 | $6.93M | +46.8% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $4.72M | -54.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $10.31M | +63.4% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $6.31M | +0.5% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $6.28M | +615.8% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $877.0K | +1.0% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $868.0K | +1.9% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $852.0K | n/a | 2016-03-15, From 2013-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $7.67M | +21.7% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $9.05M | -21.0% |
| Bioventus Inc. (BVS) | 2025-12-31 | $2.56M | +154.7% |
| Artivion, Inc. (AORT) | 2025-12-31 | $39.04M | +249.0% |
| UFP Technologies Inc (UFPT) | 2024-12-31 | $9.66M | -8.0% |
| Accuray Inc (ARAY) | 2026-06-30 | $5.86M | +37.2% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $26.65M | -37.8% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $46.34M | +36.5% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $42.45M | -49.0% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗